GNOMvsSPDW
Global X Genomics & Biotechnology ETF against SPDR Portfolio Developed World ex-US ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| GNOM | SPDW | |
|---|---|---|
| Expense ratio | 0.50% | 0.030% |
| Assets | $85M | $41B |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | +$4.9B |
| Return, YTD | +48.7% | +13.8% |
| Return, 1 year | +64.6% | +15.7% |
| Avg daily volume | 37K | 2.6M |
| Holdings | 41 | 2480 |
| Listed | Apr 5, 2019 | Apr 20, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS